- Innovation Award in 2019 at City University of Hong Kong
- Fellowship in 2014 at University of Washington
Dr Chow received her bachelor’s degree in Biomedical Engineering from Duke University (Durham NC, USA). After two years of research in cancer genomics at Broad Institute and Dana-Farber Cancer Institute of Harvard and MIT (Boston MA, USA), she moved to University of California, Berkeley (Berkeley CA, USA) to pursue graduate studies in Molecular and Cell Biology. Her PhD research focused on gene regulation during B lymphocyte development and malignant transformation. With a Croucher Foundation Postdoctoral Fellowship and an NIH F32 National Research Service Award, Dr Chow conducted postdoctoral research at University of Washington (Seattle WA, USA) studying innate immune signaling and gene networks that regulate the anti-viral immune response. Dr Chow joined City University of Hong Kong in April 2018.
The Chow lab focuses on investigating what constitute a protective immune response against cancer in order to design effective cancer immunotherapy. The lab combines concepts and techniques from biochemistry, molecular and cell biology, cancer biology, immunology, virology, genomics, cell and animal models, and systems biology to dissect the molecular pathways and gene regulatory networks that modulate the anti-cancer immune response. The ultimate goal of the lab is to develop vaccines and targeted therapies that harness the natural ability of our immune system to fight cancer.
Current research themes include:
- Characterization of immune response in solid tumors
- Molecular mechanisms of effective anti-cancer immune response
- Design of cancer vaccines and adjuvants